| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/26/2012 | US20120101088 Transmembrane Penetration Enhancer |
| 04/26/2012 | US20120101086 Thiadiazole derivatives and their use for the treatment of disorders mediated by s1p1 receptors |
| 04/26/2012 | US20120101083 S1p1 agonists comprising a bicyclic n-containing ring |
| 04/26/2012 | US20120101082 Vasopressin v1a antagonists |
| 04/26/2012 | US20120101081 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors |
| 04/26/2012 | US20120101079 Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
| 04/26/2012 | US20120101078 Amide derivatives as neuropeptide y5 receptor ligands |
| 04/26/2012 | US20120101075 Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 Adrenergic Receptor |
| 04/26/2012 | US20120101070 11a, 12-Derivatives of Tetracycline Compounds |
| 04/26/2012 | US20120101043 Delta-opioid receptor selective analgesics |
| 04/26/2012 | US20120101039 Calcium-sensing receptor-active compounds |
| 04/26/2012 | US20120101028 Anti-inflammatory compounds and uses thereof |
| 04/26/2012 | US20120101026 Compounds For Enzyme Inhibition |
| 04/26/2012 | US20120101025 Compounds For Enzyme Inhibition |
| 04/26/2012 | US20120100235 Papaya puree and uses thereof |
| 04/26/2012 | US20120100229 Treatment and Prevention of White Matter Injury with KATP Channel Activators |
| 04/26/2012 | US20120100228 Chromium complexes as enhancers of brain glucose transporters |
| 04/26/2012 | US20120100219 Composition for the production of tablets, and method for the production of said composition |
| 04/26/2012 | US20120100217 Polymeric material |
| 04/26/2012 | US20120100208 Stable pharmaceutical composition and methods of using same |
| 04/26/2012 | US20120100204 TGF-Beta Stimulating Agent Compositions and Combinations |
| 04/26/2012 | US20120100190 Controlled release sterile injectable aripiprazole formulation and method |
| 04/26/2012 | US20120100189 Delayed release rasagiline malate formulation |
| 04/26/2012 | US20120100171 Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions |
| 04/26/2012 | US20120100161 Amatoxin-Armed Therapeutic Cell Surface Binding Components Designed for Tumour Therapy |
| 04/26/2012 | US20120100156 Therapeutic Agent |
| 04/26/2012 | US20120100139 CD86 Antagonist Multi-Target Binding Proteins |
| 04/26/2012 | US20120100129 N-Terminal Truncated Protofibrils/Oligomers for Use in Therapeutic and Diagnostic Methods for Alzheimer's Disease and Related Disorders |
| 04/26/2012 | US20120100127 Method to Increase the Absorption of Unsaturated Fatty Acids by Human Infants |
| 04/26/2012 | US20120100125 Local dehydration for carpal tunnel syndrome |
| 04/26/2012 | US20120100122 Combination therapy |
| 04/26/2012 | US20120100116 Neuron generation, regeneration and protection |
| 04/26/2012 | US20120100113 Differentiation method for production of glial cell populations |
| 04/26/2012 | US20120100074 Humanized antibodies against light and uses thereof |
| 04/26/2012 | DE102010049595A1 Chinazolinderivate Quinazoline derivatives |
| 04/26/2012 | DE102010042833A1 Neue Halogenalkoxychinazoline, deren Herstellung und Verwendung New Halogenalkoxychinazoline, their preparation and use |
| 04/26/2012 | CA2815353A1 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors |
| 04/26/2012 | CA2815131A1 Substituted 6-amino-nicotinamides as kcnq2/3 modulators |
| 04/26/2012 | CA2815046A1 Human antibodies and specific binding sequences thereof for use in neurological disease |
| 04/26/2012 | CA2814840A1 Sustained-release formulation for injection |
| 04/26/2012 | CA2814795A1 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain |
| 04/26/2012 | CA2813708A1 Arylamide derivatives as ttx-s blockers |
| 04/25/2012 | EP2444411A1 Tripeptide boronic acid or boronic ester, preparative method and use thereof |
| 04/25/2012 | EP2444399A1 Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842 |
| 04/25/2012 | EP2444395A1 Substituted isoquinoline derivative |
| 04/25/2012 | EP2444097A1 Nfat signal inhibitor and calcineurin inhibitor |
| 04/25/2012 | EP2444094A1 Mangiferin-berberine salt, manufacturing method and use thereof |
| 04/25/2012 | EP2444091A2 Use of toosendanin or melia azedarach extracts for preventing or treating dementia |
| 04/25/2012 | EP2443122A1 Diazahomoadamantane derivatives and methods of use thereof |
| 04/25/2012 | EP2443121A2 Gamma secretase modulators |
| 04/25/2012 | EP2443119A1 Gamma secretase modulators |
| 04/25/2012 | EP2443118A1 Gamma secretase modulators |
| 04/25/2012 | EP2443108A1 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds |
| 04/25/2012 | EP2443105A1 Novel phenylimidazole derivative as pde10a enzyme inhibitor |
| 04/25/2012 | EP2443092A1 Bicyclic and tricyclic compounds as kat ii inhibitors |
| 04/25/2012 | EP2442832A1 Compositions and methods for treatment of multiple sclerosis |
| 04/25/2012 | EP2442824A2 Protease variants |
| 04/25/2012 | EP2442820A1 Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders |
| 04/25/2012 | EP2442819A2 Treatment of inflammatory disorders, cardiovascular diseases and acute ischemic brain stroke with ozone |
| 04/25/2012 | EP2442810A2 Reversal of l-dopa-induced dyskinesia by neuronal nicotinic receptor ligands |
| 04/25/2012 | EP2442808A2 Composition for transporting orotic acid across the blood-brain barrier |
| 04/25/2012 | EP2442797A1 Dendrimer based nanodevices for therapeutic and imaging purposes |
| 04/25/2012 | EP2442655A1 Compositions and methods for treating amyotrophic lateral sclerosis |
| 04/25/2012 | EP2442650A1 Sublingual apomorphine |
| 04/25/2012 | EP2442649A1 The use of metabotropic glutamate receptor potentiators for reducing nicotine dependence |
| 04/25/2012 | EP2247586B1 2-aza-bicyclo[2.2.1]heptane derivatives |
| 04/25/2012 | EP1909600B1 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
| 04/25/2012 | EP1828137B1 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments |
| 04/25/2012 | EP1685152B1 Il-18 binding proteins |
| 04/25/2012 | EP1650205B1 Cyclohexanecarboxylic acid compound |
| 04/25/2012 | EP1570847B1 Phosphodiesterase 10a inhibitors for use in the treatment of parkinson's disease, huntington's disease and schizophrenia |
| 04/25/2012 | EP1503748B1 2,2'-Dithio-bis(ethanesulfonate) for use in inhibiting paclitaxel-induced abnormal thermoesthesia |
| 04/25/2012 | EP1381432B9 HSA-free formulations of interferon-beta |
| 04/25/2012 | CN1278733B Viscous compositions containing carbon dioxide |
| 04/25/2012 | CN102428101A 用于治疗用途的方法 A method for therapeutic use |
| 04/25/2012 | CN102428084A 化合物 Compound |
| 04/25/2012 | CN102428081A 艾波度坦(men15596)和相关中间体的制备方法 Preparation Appleby degrees Tanzania (men15596) and related intermediates |
| 04/25/2012 | CN102428080A 神经营养因子活性参与的疾病的治疗或预防剂 Neurotrophic agent for treating or preventing diseases associated with the activity of Factor |
| 04/25/2012 | CN102428078A 神经保护、降胆固醇以及抗癫痫的化合物 Neuroprotection, cholesterol and antiepileptic compounds |
| 04/25/2012 | CN102428074A α-(N-苯磺酰氨基)环烷基衍生物 α- (N- phenyl-sulfonyl-amino) cycloalkyl derivatives |
| 04/25/2012 | CN102428069A 丙烯酰胺化合物及其用途 Acrylamide compounds and use thereof |
| 04/25/2012 | CN102427852A Compositions and methods for inhibiting expression of glucocorticoid receptor (GCR) genes |
| 04/25/2012 | CN102427810A 作为trpm8拮抗剂的氨磺酰基苯甲酸衍生物 As trpm8 antagonists sulfamoyl benzoic acid derivative |
| 04/25/2012 | CN102424818A Caspase-1-ES cell line induced by mifepristone |
| 04/25/2012 | CN102423474A 肺、心两经非解表中药注射液及生产方法 Lung, heart two non-relieving medicine by injection and production methods |
| 04/25/2012 | CN102423471A 心、胃两经非解表中药注射液及生产方法 Heart, stomach two non-relieving medicine by injection and production methods |
| 04/25/2012 | CN102423470A 心经非解表中药注射液及生产方法 Heart Sutra Non-relieving medicine injection and production methods |
| 04/25/2012 | CN102423463A 肝、心两经非解表中药注射液及生产方法 Liver, heart and two non-relieving medicine by injection and production methods |
| 04/25/2012 | CN102423452A 肾、心两经非解表中药注射液及生产方法 Kidney, heart and two non-relieving medicine by injection and production methods |
| 04/25/2012 | CN102423450A 脾、心两经非解表中药注射液及生产方法 Spleen, heart two non-relieving medicine by injection and production methods |
| 04/25/2012 | CN102423448A 一种中药戒毒糖浆及其制备工艺 A traditional Chinese medicine treatment syrup and preparation process |
| 04/25/2012 | CN102423443A 一种用于治疗失眠症的双组方药物及其制备方法 A double treat insomnia prescription drugs and their preparation method |
| 04/25/2012 | CN102423437A 一种用于治疗中风偏瘫的双组方药物及其制备方法 A two-stroke hemiplegia treatment prescription drugs and their preparation method |
| 04/25/2012 | CN102423431A 小肠、心两经非解表中药注射液及生产方法 Small intestine, heart two non-relieving medicine by injection and production methods |
| 04/25/2012 | CN102423380A 一种清肝胆实火燥湿的药物组合 A pharmaceutical composition hepatobiliary real fire to clear dampness |
| 04/25/2012 | CN102423371A 一种中药戒毒烟及其制备工艺 Smoke a traditional Chinese medicine treatment and preparation process |
| 04/25/2012 | CN102423364A 一种治疗面瘫的牵正膏药及其制备方法 A method of treating facial paralysis Qianzheng plaster and its preparation method |
| 04/25/2012 | CN102423355A 缓解焦虑、安神静心的芳香植物复方精油 Relieve anxiety, sedative meditation aromatic plant oil compound |
| 04/25/2012 | CN102423331A 一种艾片的制取方法与制取设备 A moxa sheet preparation methods and preparation equipment |
| 04/25/2012 | CN102423329A 一种三七总皂苷提取液的脱色方法 Decolorization method of total saponin extract of Panax |